Microbial Composition and Stool Short Chain Fatty Acid Levels in Fibromyalgia

Yunkyung Kim, Geun-Tae Kim () and Jihun Kang ()
Additional contact information
Yunkyung Kim: Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan 49267, Republic of Korea
Geun-Tae Kim: Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan 49267, Republic of Korea
Jihun Kang: Department of Family Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan 49267, Republic of Korea

IJERPH, 2023, vol. 20, issue 4, 1-12

Abstract: Background: The present study aimed to evaluate microbial diversity, taxonomic profiles, and fecal short chain fatty acid (SCFA) in female patients with fibromyalgia syndrome (FMS). Methods: Forty participants (19 patients with FMS and 21 controls) were included in the study, and the diagnosis of FMS was made based on the revised American College of Rheumatology criteria. DNA extraction from fecal samples and 16S rRNA gene sequencing were conducted to estimate microbial composition. To compare alpha diversity, the Shannon index accounting for both evenness and richness, Pielou’s evenness, and Faith’s phylogenetic diversity (PD) were calculated. Unweighted and weighted UniFrac distances, Jaccard distance, and Bray–Curtis dissimilarity were used to calculate beta diversity. Furthermore, stool metabolites were analyzed using gas chromatography-mass spectrometry, and a generalized regression model was used to compare the SCFA of stools between FMS and healthy controls. Results: Compared with the control, patients with FMS had lower observed OTU ( p = 0.048), Shannon’s index ( p = 0.044), and evenness ( p < 0.001). Although patients with FMS had a lower PD than did controls, statistical significance was not reached. We observed significant differences in unweighted ( p = 0.007), weighted UniFrac-based diversity ( p < 0.005), Jaccard distance ( p < 0.001), and Bray–Curtis dissimilarity ( p < 0.001) between the two groups. Although the FMS groups showed lower propionate levels compared with those of the control group, only marginal significance was observed (0.82 [0.051] mg/g in FMS vs. 1.16 [0.077] mg/g in the control group, p = 0.069). Conclusions: The diversity of the microbiome in the FMS group was lower than that in the control group, and the reduced stool propionate levels could be associated with the decreased abundance of propionate-producing bacteria.

Keywords: fibromyalgia; gastrointestinal microbiome; short chain fatty acids; metabolome; brain–gut axis (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/4/3183/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/4/3183/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2023:i:4:p:3183-:d:1065528

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().